Cannabis One Expects to See $9 Million in Annual Contract Fee Revenue

Cannabis One Holdings

As the cannabis industry gains more traction across the globe, more and more companies are looking to gain a share of the multi-billion dollar market. This feverish push to capitalize on cannabis has led to overcrowding in a very fragmented market, which in turn causes uncertainty amongst investors. Luckily, companies like Cannabis One Holdings Inc. (CSE:CBIS) (OTC:CAAOF) are working to become a definitive source of unparalleled product selection.

Cannabis One provided an operational update on Thursday to report on its continued growth and brand reach, which highlights the company’s ability to aggregate and optimize popular brands.

One example is its award-winning Honu brand line, which has continued to exceed the company’s expectations. Cannabis One acquired Honu brand assets in May and has seen massive success with it already.

Cannabis One Ramps Up Sales in Washington State

Cannabis One’s licensed partner (LP) commenced production of concentrates under the Honu brand label in Washington State and has reported that based on pre-orders received to-date and current sales channel data, Honu-branded concentrates are anticipated to generate approximately $850,000 USD per year in annualized brand manufacturing contract fee revenue, at an estimated EBITDA margin of about 35%, assuming product demand aligns with the LP’s forecasted manufacturing and sales goals.

The company’s LP also introduced and launched sales of Cannabis One’s INDVR Strains disposable vaporizer products in the Washington market, which is expected to offer annualized brand manufacturing contract fee revenue that exceeds $1.2 million USD per year, at an estimated EBITDA of 30%, again assuming the LP meets its manufacturing and sales targets.

Capitalize off Cannabis
Sign up now to start receiving our investing insights for FREE!

 

Cannabis One’s Washington-based LP has also been given state approval to commence the production and sale of certain infused products under the Evergreen Organix brand label, which is expected to bring in approximately $4 million USD yearly, at an estimated EBITDA of 35% upon the closing of the definitive agreement.

>> TGOD Stock Leaps on the Launch of Global Strategic Hemp Division

Cannabis One Continues to Grow Brand Presence in Oregon

Cannabis One is also seeing a lot of progress and success from its LPs in Oregon, which just received approval for 18 SKUs labeled under the Honu brand. This includes nine THC-based products and nine CBD-based products.

According to initial sales orders already received, Cannabis One can anticipate annualized brand manufacturing contract fee revenue to generate roughly $1.1 million USD annually.

Oregon State has also approved a 50-milligram edible Honu-branded SKU. This unconventional, but popular Honu-branded edible is expected to produce an estimated $1.2 million USD per year, at an estimated gross margin of about 77%.

Cannabis One is also making progress with the development of its proposed Oregon manufacturing and processing facilities, which it intends to use for the production of both THC and CBD products. The company has received the necessary governmental and regulatory approvals and anticipate the development of the 21,000 square foot facility, which will be designed and built in accordance with GMP (Good Manufacturing Practices) standards, to commence in July.

Meanwhile, on the other side of the nation, Cannabis One Holdings just revealed the opening and rebranding of its new state-of-the-art The Joint™ dispensary in Denver, which will feature an inviting, mid-modern interior decor that has an upscale vibe.

It is evident that Cannabis One did its homework when it decided to acquire these brands, as both Honu and Evergreen products are already gaining traction within just a month.

Investors who are interested in the cannabis space will definitely want to watch for what Cannabis One Holdings does next. The exciting update from the company caused its share price to increase by 3.06% to $0.70 USD as of 2:30 pm EST on the OTC. Meanwhile, CBIS’s share price was down 1.12% on the CSE at $0.88 CAD.

>> Read More Cannabis One News

Featured Image: Canva

Please See Disclaimer


Disclosure:

1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on my research and understanding of the sector.

2) The Article was issued on behalf of a third party, Cannabis One Holdings Inc. Market Jar Media Inc. has or expects to receive the following amounts from Native Ads Inc. in the amount of two hundred sixty four thousand US dollars for 22 campaign days (16 business days). In addition, Market Jar was re-engaged by Native Ads for a period of 23 campaign days (17 business days) in the amount of two hundred thirty two thousand five hundred thirty CA dollars.

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on Market Jar Media Inc. should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on Market Jar Media Inc.

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.